Substance / Medication

Papaverine

Overview

Active Ingredient
papaverine
RxNorm CUI
7895

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

3 trials linked to this intervention

3
Total Trials
0
Recruiting
1
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Papaverine prior to catheter balloon insertion for labor induction: a randomized controlled trial.
Abu Shqara Raneen, Nakhleh Francis Yara, Goldinfeld Gabriela et al. · Am J Obstet Gynecol MFM · 2024
PMID: 38825005RCT
Effect of Papaverine on Renal Artery Blood Flow during Robot-Assisted Partial Nephrectomy: A Randomized Controlled Study.
Yu Jihion, Park Jun-Young, Hwang Jai-Hyun et al. · Ann Surg Oncol · 2022
PMID: 35368220RCT
Effect of Papaverine on Left Internal Mammary Artery Flow: Topical Spraying versus Perivascular Injection Method.
Gowda Girish, Kumar Jayanth, G S Veeresh et al. · Braz J Cardiovasc Surg · 2020
PMID: 32369298RCTFull text (PMC)
Treatment of loin pain suspected to be renal colic with papaverine hydrochloride: a prospective double-blind randomised study.
Asgari Seyed Alaeddin, Asli Mani Mohiti, Madani Ali Hamidi et al. · BJU Int · 2012
PMID: 22348304RCT
Role of papaverine hydrochloride administration in patients with intractable renal colic: randomized prospective trial.
Yencilek Faruk, Aktas Can, Goktas Cemal et al. · Urology · 2008
PMID: 18789511RCT
Clinical Efficacy of Intracoronary Papaverine After Nicorandil Administration for Safe and Optimal Fractional Flow Reserve Measurement.
Inoue Konosuke, Sonoda Shinjo, Naka Yutaro et al. · Int Heart J · 2021
PMID: 34544970Observational
Pregnancy outcomes following gestational exposure to papaverine: An observational comparative study.
Gueta Itai, Braun Adi, Gilan Adi et al. · Br J Clin Pharmacol · 2021
PMID: 33675044Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Papaverine (substance)
SNOMED CT
372784001
UMLS CUI
C0030350
RxNorm CUI
7895

Clinical Data

This intervention maps to 9 entities in the Ltrl knowledge graph.

9
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
3
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.